Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Near pan-β-lactam resistance in NDM-producing Escherichia coli with PBP3 insertions is overcome by dual PBP2/PBP3 inhibition.

npj antimicrobials and resistance·2026
Same author

Fisetin prevents deterioration of cellular functions in amyotrophic lateral sclerosis variants G262R and P438L of SQSTM1 in SH-SY5Y cells.

Toxicology and applied pharmacology·2026
Same author

The Toxin of the Year: Airborne PM<sub>2.5</sub>.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Decoy oligonucleotide technology in cancer therapy: molecular mechanisms, challenges, and translational potential.

Medical oncology (Northwood, London, England)·2026
Same author

Co-Administration of LPC and LPS Enhanced the Spinal Cord Vulnerability in a Mouse Model of Focal Demyelination.

Journal of molecular neuroscience : MN·2026
Same author

Exploring the Potential of Calebin-A in Targeting Obesity-Related Genes and Pathways.

Journal of cellular and molecular medicine·2026

Related Experiment Video

Updated: Jun 12, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.6K

Lymphatic targeting for therapeutic application using nanoparticulate systems.

Nidhi Singh1, Mayank Handa1, Vanshikha Singh2

  • 1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, Lucknow, India.

Journal of Drug Targeting
|June 20, 2022
PubMed
Summary

Nanotechnology enhances drug delivery to the lymphatic system for treating diseases. Despite progress, challenges remain in developing clinically available nanocarrier products for lymphatic targeting.

Keywords:
Lymphatic targeted deliveryanticancerantimicrobialsdrug deliveryimmunotherapynanocarriersvaccines

More Related Videos

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.0K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K

Related Experiment Videos

Last Updated: Jun 12, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.6K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.0K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Pharmacology

Background:

  • The lymphatic system is crucial for immune responses and fluid balance, making it a key target for drug delivery.
  • Conventional drug delivery methods have limitations in targeting specific lymphatic sites effectively.
  • Nanotechnology offers novel strategies to improve drug localization and therapeutic efficacy within the lymphatic system.

Approach:

  • This review examines the pathophysiology of the lymphatic system and disease-induced alterations.
  • It analyzes drug characteristics and physicochemical properties influencing lymphatic uptake of nanocarriers.
  • The study highlights advancements in nanocarrier-based drug delivery for lymphatic targeting.

Key Points:

  • Nanocarriers can be engineered to target the lymphatic system for improved drug delivery.
  • Successful preclinical studies demonstrate the potential of nanomedicine for treating various diseases.
  • Factors like particle size, surface charge, and formulation impact lymphatic uptake.

Conclusions:

  • Significant progress has been made in utilizing nanocarriers for lymphatic drug delivery.
  • Clinical translation of these nanomedicines faces challenges, including formulation stability and large-scale production.
  • Further research is needed to overcome existing hurdles and bring nanocarrier-based lymphatic therapies to patients.